Myostatin-related muscle hypertrophy
Dernière mise à jour 2 Oct 2024
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
Myostatin-related muscle hypertrophy is a rare condition characterised by reduced body fat and increased muscle size. Affected individuals have up to twice the usual amount of muscle mass in their bodies. They also tend to have increased muscle strength. Myostatin-related muscle hypertrophy is not known to cause any medical problems, and affected individuals are intellectually normal.
Sélections vidéo pour Conditions génétiquesBibliothèque vidéo
Description
Myostatin-related muscle hypertrophy is a rare condition characterised by reduced body fat and increased muscle size. Affected individuals have up to twice the usual amount of muscle mass in their bodies. They also tend to have increased muscle strength. Myostatin-related muscle hypertrophy is not known to cause any medical problems, and affected individuals are intellectually normal.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
Muscle hypertrophy syndrome
Related patient information and medicines

Patient information leaflet
Puis-je prendre Atorvastatine et Pyridostigmine ensemble ?
There is a potential for increased muscle-related side effects when taking these two medicines together. Both drugs can independently affect muscle function; atorvastatin can cause muscle aches or weakness (myopathy), et pyridostigmine is used to treat faiblesse musculaire dans conditions aimer myasthenia gravis. Taking them together might make it harder.

Patient information leaflet
dystrophie musculaire
Muscular dystrophy is an inherited (genetic) disorder causing muscle weakness. There are different types of muscular dystrophy, which vary as to how severe they are, rangi... Muscular dystrophy (MD) is the name given to a group of disorders which cause progressive muscle weakness (meaning it gets worse over time). These are: Muscle wasting - in.

Patient information leaflet
Puis-je prendre Atorvastatine et Prednisolone ensemble ?
Prendre atorvastatin and prednisolone together may increase the risk of muscle-related side effects, tel que muscle pain, tenderness, or weakness. In rare cases, this can lead to a serious condition called rhabdomyolysis, where muscle t... Why this happens Both medications can independently cause muscle toxicity (myopathy). Furthermore,.

Patient information leaflet
Faiblesse musculaire
This leaflet looks at types of faiblesse musculaire and discusses the wide range of problems which can cause them. Faiblesse musculaire is a common complaint but the word weakness can mean different things to different people - including tiredness, reduced power and failure to work at all. Muscle 'fatiga... This often goes along with muscle tiredness but is.

Patient information leaflet
Puis-je prendre Bisoprolol et Simvastatine ensemble ?
There is no direct interaction between bisoprolol and simvastatin. However, both médicaments can occasionally cause muscle-related side effects, tel que weakness or fatigue. While... Why this happens Bisoprolol is a beta-blocker used for heart rate and blood pressure, while simvastatin is a statin used for cholesterol. Grapefruit contains a.

Patient information leaflet
Puis-je prendre Atorvastatine et Tamsulosine ensemble ?
There is no known direct interaction between atorvastatin and tamsulosin. Why this happens Atorvastatin and tamsulosin are processed by different pathways in the body and do not interfere with how the other drug works or is cl... Muscle disorders - atorvastatine Seek immediate medical advice if you experience unexplained muscle pain, tenderness, or.
Lectures complémentaires et références
- Myostatin-related muscle hypertrophy; MedlinePlus, National Library of Medicine.
- Carnac G, Ricaud S, Vernus B, Bonnieu A. Myostatin: biology and clinical relevance. Mini Rev Med Chem. 2006 Jul;6(7):765-70. doi: 10.2174/138955706777698642.
- Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJ. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med. 2004 Jun 24;350(26):2682-8. doi: 10.1056/NEJMoa040933. No abstract available.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

